Emergency Insulin Dose Control With Backup Therapy Tracking
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing glucose level control systems and ambulatory medical devices face challenges in providing seamless therapy delivery, user-friendly control, and efficient management of glucose control agents without interrupting therapy, especially in scenarios requiring emergency dose adjustments.
Innovation Solution
The implementation of glucose level control systems (GLCS) that include software updates, gesture-based control, automatic therapy resumption, improved alarm management, wide area network connectivity, and security features, along with the ability to generate emergency dose control signals and track insulin therapy, enabling autonomous dosing recommendations and backup protocols.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If software updates are implemented in glucose level control systems, then system functionality and security are improved, but therapy delivery interruption occurs
Solution Approach 1:
The software system is divided into multiple independent components including a primary application and a backup application. The backup application can take over therapy delivery functions when the primary application is updated, allowing software updates without interrupting therapy. This segmentation enables independent updating of software components while maintaining continuous therapeutic function.
Solution Approach 2:
A backup application is prepared and validated in advance before the primary application needs updating. The backup application is pre-loaded and tested to ensure it can immediately assume therapy delivery responsibilities. This preliminary preparation ensures that when updates are needed, the transition can occur without interrupting therapy delivery.
2Reliability
If emergency dose control signals are generated for modified glucose control therapy, then patient safety is improved, but system complexity increases
Solution Approach 1:
The glucose level control system includes automated monitoring and decision-making capabilities that allow it to self-manage emergency situations. The system automatically detects critical glucose levels, generates appropriate emergency dose control signals, and executes modified therapy protocols without requiring complex external intervention. This self-service approach enhances patient safety while keeping the control system architecture relatively simple.
Solution Approach 2:
The system implements continuous feedback loops that monitor glucose levels, therapy delivery status, and system operational parameters. This feedback mechanism enables the system to automatically detect emergency conditions and generate appropriate dose control signals based on real-time data, improving patient safety through automated response rather than complex manual control procedures.
3Ease of operation
If insulin therapy tracking is implemented over a tracking period, then therapy management is improved, but data storage requirements increase
Solution Approach 1:
The system extracts and stores only the most essential therapy management data including insulin dose amounts, timing information, and glucose level responses. Non-essential data is excluded or aggregated. This selective data extraction provides sufficient information for effective therapy management while minimizing data storage requirements.
Solution Approach 2:
The system implements data retention policies where temporary or redundant therapy data is discarded after serving its purpose, while critical data is preserved for long-term management. This approach maintains adequate therapy management capabilities without accumulating excessive data volumes over extended tracking periods.
Data Source
AI summary
Automated glucose level control system that provide therapy to a subject, such as glucose control, are disclosed. The system generates dose control signals using control algorithms configured to autonomously determine doses of insulin to be infused into a subject. When the system determines that an initial dose control signal does not indicate health-appropriate therapy, the system can modify a manual therapy instruction and transmit an emergency dose control signal to the medicament pump. Disclosed systems and devices can track insulin therapy administered to the subject over a tracking period, including storing an indication of the autonomously determined doses of insulin delivered to the subject. The system can generate a backup therapy protocol with insulin therapy instructions based at least in part on the insulin therapy administered to the subject over the tracking period.